Real-time enrollment status for this androgen deprivation therapy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:32 PM UTC
| NCT Number | NCT05327465 |
| Recruiting Status | Recruiting |
| Condition | Androgen Deprivation Therapy |
| Phase | Clinical Trial |
| Target Enrollment | 62 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of July 13, 2026: Clinical trial NCT05327465 is currently recruiting participants. This clinical trial study for androgen deprivation therapy is actively seeking new participants at 1 location across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05327465 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05327465 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.